Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Klarna (KLAR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Klarna’s common stock IPO traceable to September 10, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Ea ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Jayud (JYD) To Contact Him Directly To Discuss Their Options If you purchased or acquired Jayud securities between April 21, 2023, and April 30, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- What’s Happening? Bragar Ea ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Freeport (FCX) To Contact Him Directly To Discuss Their Options If you purchased or acquired Freeport securities between February 15, 2022 and September 24, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- What’s Happeni ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired Telix securities between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Bragar ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Stride (LRN) To Contact Him Directly To Discuss Their Options If you purchased or acquired Stride securities between October 22, 2024 and October 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Brag ...

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corporation regarding the merger with Cedar Fair, alleging that the registration statement failed to disclose significant underinvestment issues and operational challenges faced by Legacy Six Flags prior to the merger [2][7]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities who purchased or acquired Six Flags common stock related to the merger registration statement issued on July 1, 2024 [2]. - Investors have until January 5, 2026, to apply to the Court to be appointed as lead plaintiff in the lawsuit [2]. Group 2: Allegations - The registration statement allegedly did not reveal that Legacy Six Flags had chronic underinvestment and required millions in additional capital and operational expenditures to maintain its market share [7]. - Following the appointment of CEO Selim Bassoul in November 2021, significant employee layoffs were made to cut costs, which reportedly degraded operational competence and guest experience [7]. - On the merger closing date, Six Flags stock was trading above $55 per share, but subsequently fell to as low as $20 per share, marking a decline of nearly 64% [7]. Group 3: Next Steps for Investors - Investors who suffered losses or have information regarding the claims are encouraged to contact the law firm for further details and assistance [4].

Core Viewpoint - A class action lawsuit has been filed against Klarna Group plc for allegedly misleading investors regarding the company's financial health and risk disclosures related to its IPO on September 10, 2025 [8]. Allegation Details - The lawsuit claims that Klarna's Registration Statement contained false and misleading statements, particularly regarding the underestimation of loss reserves that would increase shortly after the IPO [8]. - It is alleged that the defendants either knew or should have known about the risk profile of individuals taking Klarna's buy now, pay later loans, which contributed to the misleading nature of their public statements [8]. Financial Impact - Klarna's IPO involved the sale of 34,311,274 shares at a price of $40.00 per share [8]. - Following the announcement of disappointing Q3 2025 financial results on November 18, 2025, which included a significant increase in credit loss provisions, Klarna's share price fell by $3.25, or approximately 9.3%, from $34.88 to $31.63 [8]. Next Steps - Investors who purchased Klarna shares and suffered losses are encouraged to contact Bragar Eagel & Squire, P.C. to discuss their legal rights and options [4]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is February 20, 2026 [8]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various types of litigation, including securities and commercial litigation [5].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avantor (AVTR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Avantor common stock between March 5, 2024, and October 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- What’s Happening: ...

Core Points - A class action lawsuit has been filed against Baxter International, Inc. for allegedly misleading investors regarding the safety and efficacy of its Novum LVP devices, which reportedly suffered systemic defects leading to serious patient risks [3][7] - The lawsuit covers individuals who purchased Baxter common stock between February 23, 2022, and October 29, 2025, with a deadline of December 15, 2025, for investors to apply as lead plaintiffs [7] Allegation Details - The complaint claims that Baxter failed to disclose critical information about the Novum LVP, including systemic defects causing malfunctions such as underinfusion, overinfusion, and non-delivery of fluids, which posed risks of serious injury or death to patients [3] - Baxter was allegedly aware of multiple device malfunctions, injuries, and deaths related to these defects but did not take adequate remedial measures, leading to continued harm [3] - The lawsuit suggests that Baxter's statements regarding the safety, efficacy, product rollout, customer feedback, and sales prospects of the Novum LVPs were materially false and misleading [3] Next Steps - Investors who suffered losses and wish to learn more about the claims or have questions are encouraged to contact the law firm Bragar Eagel & Squire, P.C. for further information [4] - The firm emphasizes that there is no cost or obligation for investors to inquire about their rights [4] About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm with a focus on representing individual and institutional investors in complex litigation across state and federal courts [5]

Core Viewpoint - A class action lawsuit has been filed against Telix Pharmaceuticals Limited for allegedly making false and misleading statements regarding its prostate cancer therapeutic candidates and supply chain quality, leading to investor losses during the specified Class Period [3][7]. Allegation Details - The lawsuit claims that defendants materially overstated the progress of Telix's prostate cancer therapeutic candidates [3]. - It is alleged that the quality of Telix's supply chain and partners was also overstated [3]. - As a result, statements made by the defendants about Telix's business, operations, and prospects were materially false and misleading, lacking a reasonable basis [3]. Next Steps - Investors who purchased or acquired Telix shares and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is January 9, 2026 [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across the United States [5].